Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein

HUMPOLÍKOVÁ ADÁMKOVÁ, L., KOVAŘÍK, J., DUŠEK, L., LAUEROVÁ, L., BOUDNÝ, V., FAIT, V., FOJTOVÁ, Miloslava, KREJČÍ, E., KOVAŘÍK, Aleš. Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein. European Journal of Cancer. 2009, 45(-), 1315-1323. ISSN 0959-8049. E-ISSN 1879-0852. Available: doi: 10.1016/j.ejca.2009.01.009